ArticleJournal of translational medicine2014

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer.

Anahit Ghochikyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.